Corbus Pharmaceuticals Holdings Stock Forecast
Big movements in Corbus Pharmaceuticals Holdings stock price on Thursday moving 13.64% between high and low
(Updated on Mar 28, 2024)
The Corbus Pharmaceuticals Holdings stock price gained 10.32% on the last trading day (Thursday, 28th Mar 2024), rising from $35.57 to $39.24. During the last trading day the stock fluctuated 13.64% from a day low at $35.16 to a day high of $39.96. The price has fallen in 6 of the last 10 days and is down by -13.05% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 61 thousand more shares were traded than the day before. In total, 235 thousand shares were bought and sold for approximately $9.22 million.
The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $36.24 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 308.44% during the next 3 months and, with a 90% probability hold a price between $148.04 and $222.61 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
CRBP Signals & Forecast
The Corbus Pharmaceuticals Holdings stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $36.98 and $33.11. A breakdown below any of these levels will issue sell signals. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, March 13, 2024, and so far it has fallen -16.65%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).
Support, Risk & Stop-loss for Corbus Pharmaceuticals Holdings stock
On the downside, the stock finds support just below today's level from accumulated volume at $34.60 and $30.90. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Corbus Pharmaceuticals Holdings finds support just below today's level at $34.60. If this is broken, then the next support from accumulated volume will be at $30.90 and $29.49.
This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $4.80 between high and low, or 13.64%. For the last week, the stock has had daily average volatility of 9.31%.
Our recommended stop-loss: $36.82 (-6.16%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from a pivot top found 11 days ago.)
Trading Expectations (CRBP) For The Upcoming Trading Day Of Monday 1st
For the upcoming trading day on Monday, 1st we expect Corbus Pharmaceuticals Holdings to open at $38.12, and during the day (based on 14 day Average True Range), to move between $35.07 and $43.41, which gives a possible trading interval of +/-$4.17 (+/-10.62%) up or down from last closing price. If Corbus Pharmaceuticals Holdings takes out the full calculated possible swing range there will be an estimated 21.25% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $40.32 (2.75%) than the support at $34.60 (11.82%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Corbus Pharmaceuticals Holdings stock A Buy?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Corbus Pharmaceuticals Holdings stock to perform well in the short-term.
Current score: 3.875 Buy Candidate Unchanged
Predicted Opening Price for Corbus Pharmaceuticals Holdings of Monday, April 1, 2024
Fair opening price April 1, 2024 | Current price |
---|---|
$38.12 ( 2.85%) | $39.24 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for CRBP
Fibonacci Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 42.92 | 9.37 % | |
R2 | 41.09 | 4.70 % | ||
R1 | 39.95 | 1.82 % | ||
Current price: | 39.24 | |||
Support | S1 | 36.29 | -7.52 % | |
S2 | 35.16 | -10.41 % | ||
S3 | 33.32 | -15.07 % |
Accumulated Volume Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 44.93 | 14.50 % | |
R2 | 43.68 | 11.31 % | ||
R1 | 40.32 | 2.75 % | ||
Current price | 39.24 | |||
Support | S1 | 34.60 | -11.82% | |
S2 | 30.90 | -21.25% | ||
S3 | 29.49 | -24.85% |
FAQ
Click here for our free guide on how to buy Corbus Pharmaceuticals Holdings Stock.